ArticleMolecular cancer therapeutics2009

Rosiglitazone inhibits alpha4 nicotinic acetylcholine receptor expression in human lung carcinoma cells through peroxisome proliferator-activated receptor gamma-independent signals.

Xiaojuan Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.